Maven Securities »

Aeglea Biotherapeutics shares owned by Maven Securities

Quarter-by-quarter ownership of Aeglea Biotherapeutics (SYRE) shares owned by Maven Securities from 13F filings

Historical chart of Maven Securities investment in Aeglea Biotherapeutics

Tip: Access up to 7 years of quarterly data

All positions including Aeglea Biotherapeutics held by Maven Securities consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Aeglea Biotherapeutics by Maven Securities

Quarter filed Position value Share count Share price at filing
2026-06-30 $3.6M 40k 88.78

More positions owned by Maven Securities

Vaneck Etf Trust Call Call Option
Ishares Tr Call Call Option
Vaneck Etf Trust Put Put Option
State Str Spdr S&p 500 Et F T Put
Microsoft Corp Put Put Option
Invesco Qqq Tr Put Put Option
Micron Technology Call Call Option
Select Sector Spdr Tr Put Put Option
Meta Platforms Put Put Option
Microsoft Corporation (MSFT)
Unitedhealth Group Put Put Option
Select Sector Spdr Tr Call Call Option
Nvidia Corporation Put Put Option
Advanced Micro Devices In C Call
Ishares Tr Put Put Option

View all positions for Maven Securities

Top funds holding Aeglea Biotherapeutics

FMR
BlackRock
Perceptive Advisors
Rtw Investments
Paradigm Biocapital Advisors
Vanguard Capital Management
VR Adviser
Driehaus Capital Management
State Street Corporation
Geode Capital Management
Vanguard Portfolio Management
Jupiter Topco
TCG Crossover Management
Tang Capital Management
Bank of America Corporation

View all funds holding Aeglea Biotherapeutics